In this article, we will discuss the 10 Best German Stocks to Buy According to Analysts. The conflict in the Middle East has raised fears of economic damage as shipping costs and energy prices rise ...

Azenta (NASDAQ:AZTA) executives outlined the strategic and financial rationale for the company’s planned acquisition of UK Biocentre during a recorded conference call held Tuesday, March 10, 2026.

Bayer AG (OTCMKTS:BAYRY) is among the best German stocks to buy according to analysts. On March 5, Bayer AG (OTCMKTS:BAYRY) announced that the FDA has cleared its MEDRAD MRXperion MR injector system ...

BridgeBio Pharma (NASDAQ:BBIO) highlighted accelerating U.S. uptake for its transthyretin (TTR) stabilizer Attruby and laid out key timelines for upcoming launches and pipeline programs during a ...

(Bloomberg) -- European stocks hit a session low after Iranian Supreme Leader Mojtaba Khamenei said the Straight of Hormuz should stay closed, adding to concerns over disruption to global oil supplies ...

On March 4, 2026, Azenta announced that its subsidiary Azenta UK Ltd had completed the acquisition of UK Biocentre Limited, a UK-based provider of sample management, storage and high-throughput ...

HSBC and Standard Chartered are expected to be among the first institutions licensed to issue stablecoins in Hong Kong, positioning two of the city’s major lenders at the centre of the government’s ...

Will the stock finally be discovered? The Canadians are the first company to establish the royalty financing model, already well-established in many industries such as pharmaceuticals, biotech, ...

Biotechnology firm Scholar Rock is poised to make a significant strategic shift from a development-stage company to a commercial entity. The catalyst for this t ...

Praxis Precision Medicines focuses on clinical-stage therapies for central nervous system disorders, targeting unmet needs in neurology.

Positions Lifeward as a diversified biomedical innovation company with clear path to profitabilityIntegration of Oramed’s POD™ oral delivery ...

Evotec will cut 800 employees in its second layoff round since 2024. Elsewhere, Ultragenyx got a needed win and a twice-rejected cell therapy is getting an audience at the FDA.